Telescope Innovations Corp. (CSE:TELI)

Market Cap	28.28M +54.9%
Revenue (ttm)	6.28M +58.2%
Net Income	-2.43M
EPS	-0.04
Shares Out	80.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,500
Average Volume	118,799
Open	0.3550
Previous Close	0.3600
Day's Range	0.3500 - 0.3650
52-Week Range	0.2300 - 0.6500
Beta	1.57
RSI	37.98
Earnings Date	Jan 27, 2026

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In fiscal year 2025, Telescope Innovations's revenue was 4.78 million, an increase of 12.03% compared to the previous year's 4.27 million. Losses were -1.56 million, 18.1% more than in 2024.